摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

10H-pyrido[4',3':5,6]pyrazino[2,3-b]indole | 174320-71-9

中文名称
——
中文别名
——
英文名称
10H-pyrido[4',3':5,6]pyrazino[2,3-b]indole
英文别名
10H-pyrido<4',3':5,6>pyrazino<2,3-b>indole;2,5,9,17-Tetrazatetracyclo[8.7.0.03,8.011,16]heptadeca-1,3(8),4,6,9,11,13,15-octaene
10H-pyrido[4',3':5,6]pyrazino[2,3-b]indole化学式
CAS
174320-71-9
化学式
C13H8N4
mdl
——
分子量
220.233
InChiKey
UPYCTMLDHZEWBO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    464.0±37.0 °C(Predicted)
  • 密度:
    1.50±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    17
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    54.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Liquid Crystal Display Operating in a Vertically Aligned Mode
    申请人:Palto Serguei Petrovich
    公开号:US20100118241A1
    公开(公告)日:2010-05-13
    The present invention relates generally to the field of liquid crystal display devices and more particularly to a liquid crystal display device operating in vertically aligned mode (VA-mode) in which liquid crystal molecules having a negative dielectric anisotropy are aligned generally perpendicularly to a panel surface of the liquid crystal display. A liquid crystal display according to the invention comprises a liquid crystal cell ( 6 ) of a vertical alignment mode, at least one polarizer ( 2, 10 ) arranged on each side of the liquid crystal cell, and at least one compensating structure ( 3, 7 ) disposed between the liquid crystal cell and at least one of the polarizers. The polarizers have transmission axes ( 11, 18 ) which are perpendicular to each other.
    本发明涉及液晶显示器件领域,更具体地涉及一种在垂直对准模式(VA模式)下运行的液晶显示器件,其中具有负介电各向异性的液晶分子通常垂直于液晶显示器件的面板表面。本发明的液晶显示器包括垂直对准模式的液晶电池(6),至少一个极化器(2、10)分别设置在液晶电池的两侧,以及至少一个补偿结构(3、7)设置在液晶电池和至少一个极化器之间。极化器具有相互垂直的透过轴(11、18)。
  • 6,7-DIHYDROBENZIMIDAZO[1 ,2-C]QUINAZOLIN-6-ONE CARBOXYLIC ACIDS, THEIR ESTERS, AND METHODS OF SYNTHESIS THEREOF
    申请人:CRYSOPTIX K.K.
    公开号:EP1984373A1
    公开(公告)日:2008-10-29
  • SELF-HEALING CAPACITOR AND METHODS OF PRODUCTION THEREOF
    申请人:Capacitor Sciences Incorporated
    公开号:EP3261759B1
    公开(公告)日:2020-05-06
  • 6,7-Dihydrobenzimidazo[1,2-c]Quinazolin-6-One Carboxylic Acids, their Esters, and Methods of Synthesis Thereof
    申请人:Doutova Tatyana
    公开号:US20100047477A1
    公开(公告)日:2010-02-25
    The present invention relates to a 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one carboxylic acid and its esters of the general structural formula (I), and provides a method for their synthesis (I) where R and each R′ are selected independently from the list comprising —H—CH 3 , —C 2 H 5 , —C 3 H 7 , -iso-C 3 H 7 , —CH 2 CH 2 CH 2 CH 3 , —CH(CH 3 )CH 2 CH 3 , —CH 2 CH(CH 3 )CH 3 and —C(CH 3 ) 3 ; n is 1, 2, 3 or 4; Y is a substituent selected from the list comprising —CH 3 , —C 2 H 5 , —NO 2 , —Cl, —Br, —F, —CF 3 , —CN, —OH, —OCH 3 , —OC 2 H 5 , —OCOCH 3 , —OCN, —SCN, —NH 2 , —NHCOCH 3 ; and z is 0, 1, 2, 3 or 4.
  • ENERGY STORAGE DEVICES AND METHODS OF PRODUCTION THEREOF
    申请人:CAPACITOR SCIENCES INCORPORATED
    公开号:US20160314901A1
    公开(公告)日:2016-10-27
    The present disclosure provides an energy storage device comprising a first electrode, a second electrode, and a solid multilayer structure disposed between said first and second electrodes. The solid multilayer structure can be in contact with said first and second electrodes. The solid multilayer structure can include layers disposed parallel to said electrodes, the layers have a sequence (A-B) m -A, wherein, A is an insulating layer and B is a polarization layer comprising a colloidal composite with a micro-dispersion of electro-conductive nano-particles in an insulator matrix, and ‘m’ is a number greater than or equal to 1. Layer A can have a breakdown voltage of at least about 0.05 volts per nanometer (nm), and layer B can have a dielectric permittivity of at least about 100.
查看更多

同类化合物

氨甲酸,(5-氨基-2,3-二苯基吡啶并[3,4-b]吡嗪-7-基)-,乙基酯 咪唑并[1,5-a]吡啶并[3,2-e]吡嗪-6(5H)-酮 咪唑并[1,5-A]吡啶并[2,3-E]吡嗪-4(5H)-酮 咪唑并[1,2-a]吡啶并[3,2-E]吡嗪-6-醇 咪唑并[1,2-a]吡啶并[2,3-E]吡嗪-4(5H)-酮 吡啶并[3,4-b]吡嗪-7-胺 吡啶并[3,4-b]吡嗪-3(4h)-酮 吡啶并[3,4-b]吡嗪-2,3(1H,4H)-二酮 吡啶并[2,3-b]吡嗪-7-基硼酸频那醇酯 吡啶并[2,3-b]吡嗪-6(5H)-酮 吡啶并[2,3-b]吡嗪-2-羧酸 吡啶并[2,3-b]吡嗪-2(1h)-酮 吡啶并[2,3-b]吡嗪-2(1H)-酮,3,6-二甲基-(9CI) 吡啶并[2,3-B]吡嗪-8-甲醛 吡啶并[2,3-B]吡嗪-6-胺 吡啶并[2,3-B]吡嗪-6-羧酸 乙基[3-(4-氯苯基)-8-{[5-(二乙胺基)戊烷-2-基]氨基}吡啶并[2,3-b]吡嗪-6-基]氨基甲酸酯 乙基4-甲基-3-羰基-3,4-二氢吡啶并[2,3-b]吡嗪-2-羧酸酯 乙基(8-amino-2-{[methyl(phenyl)amino]methyl}pyrido[2,3-b]pyrazin-6-yl)氨基甲酸酯 N-乙基-N'-[3-[(4-甲基苯基)氨基]吡啶并[2,3-B]吡嗪-6-基]脲 N-[3-(4-羟基苯基)吡啶并[2,3-b]吡嗪-6-基]-N'-2-丙烯-1-基硫脲 8-甲基吡啶并[2,3-b]吡嗪 8-溴吡啶并[3,4-b]吡嗪 8-氯吡喃并[3,4-b]吡嗪 7-碘-吡啶并[2,3-b]吡嗪 7-硝基吡啶并[2,3-b]吡嗪 7-溴吡啶并[2,3-b]吡嗪 7-溴吡啶并[2,3-B]吡嗪-2,3(1H,4H)-二酮 7-溴-8-甲基吡啶并[2,3-B〕吡嗪 7-溴-6-甲基吡啶并[2,3-B]吡嗪 7-溴-2-甲基吡啶并[2,3-B]吡嗪 7-溴-2,3-二甲基吡啶并[2,3-b]吡嗪 7-氯吡啶并[3,4-b]吡嗪 7-氯-1,4-二氢吡啶并[2,3-B]吡嗪-2,3-二酮 7-氯-1,4-二氢-1-(2-丙氧乙基)-吡啶并[3,4-b]吡嗪-2,3-二酮 7-氨基吡啶并[2,3-B]吡嗪 6-肼基-3-苯基吡啶并[2,3-b]吡嗪-2-醇 6-甲氧基吡啶并[2,3-b]吡嗪-3(4h)-酮 6-溴吡啶并[2,3-B]吡嗪 6-氯咪唑并[1,5-a]吡啶并[3,2-e]吡嗪 6-氯吡啶并[3,2-B]吡嗪 6-氯吡啶并[2,3-b]吡嗪-2(1H)-酮 6-氯吡啶并[2,3-B]吡嗪-3(4H)-酮 6-氨基-3-羟基-吡啶并[2,3-B]吡嗪-2-羧酸 5-氯-吡啶[3,4-B]吡嗪 5,8-二氢-环丁[b]吡啶并[3,4-e]吡嗪-6,7-二酮 5,8-二氢-环丁[b]吡啶并[2,3-e]吡嗪-6,7-二酮 5,7-二氯吡啶并[4,3-b]吡嗪 4H-吡啶并[2,3-b]吡嗪-3-酮 4-(2,2-二甲基-1,3-二噁烷-5-基)-6-甲氧基吡啶并[2,3-B]吡嗪-3(4H)-酮